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ABSTRACT
Methylation of CpGs is generally thought to repress
transcription without significant influence from the
sequence surrounding the methylated dinucleo-
tides. Using the mouse Igf2/H19 imprinting control
region (ICR), Igf2r differentially methylated region 2
(DMR2) and bacterial sequences, we addressed how
methylation-dependent repression (MDR) from a
distance varies with CpG number, density and sur-
rounding sequence. In stably transfected F9 cells,
the methylated ICR repressed expression from a
CpG-free reporter plasmid more than 1000-fold
compared with its unmethylated control. A segment
of pBluescript, with a CpG number equal to the
ICR’s but with a higher density, repressed expres-
sion only 70-fold when methylated. A bacteriophage
lambda fragment and the Igf2r DMR2 showed mini-
mal MDR activity, despite having CpG numbers and
densities similar to or greater than the ICR. By rear-
ranging or deleting CpGs, we identified CpGs asso-
ciated with three CTCF sites in the ICR that are
necessary and sufficient for sequence-specific
MDR. In contrast to F9 cells, the methylated ICR
and pBS fragments exhibited only 3-fold reporter
repression in Hela cells and none in Cos7. Our
results show that the strength of MDR from a dis-
tance can vary a 1000-fold between different cell
types and depends on the sequence surrounding
the methylated CpGs, but does not necessarily
increase with CpG number or density.
INTRODUCTION
Methylation of CpG dinucleotides plays an important role
in the regulation of genomic activity in vertebrates.
The majority of DNA methylation is concentrated in
transposable elements and centromeric repeats, but low
levels are present across the genome (1). Consistent with
its concentration on repetitive sequences, DNA methyla-
tion inhibits transcription of transposable elements (2)
and suppresses chromosomal rearrangements between
centromeric and telomeric regions (3,4). DNA methyla-
tion is also required for maintaining X-chromosome inac-
tivation and for the allele-speciﬁc expression of imprinted
genes (5–8).
A large body of work in vivo and in cultured cells has
demonstrated a consistent correlation between promoter
methylation and gene repression (9,10). The widespread
promoter methylation of silenced genes on the inactive
X-chromosome is a clear example of this correlation
(11). Similarly, aberrant methylation commonly occurs
on the promoters of silenced tumor suppressor genes in
many types of cancer (12,13). In normal cells, genome-
wide and single gene analyses indicate that promoter
methylation of autosomal genes is rare and may be
restricted to certain pluripotency and testes-speciﬁc genes
(14,15). As expected, the presence of promoter methyla-
tion correlates well with the silencing of these genes.
Consistent with a repressive role for methylation, in vitro
methylated promoters generally show reduced expression
in transfection assays (9). In addition, many methylated
genes are induced by treating cultured cells with methyl-
transferase inhibitors (16). Although transcriptional
repression by promoter methylation is well established,
methylation is also implicated in gene silencing from a
distance by aiding the spread of heterochromatin (9,17).
The importance of chromatin in methylation-dependent
repression (MDR) is seen in the silencing of methylated
plasmids that occurs concurrently with nucleosome depo-
sition (18,19).
DNA methylation appears to mediate repression
through multiple mechanisms. At some promoters, methy-
lation directly prevents activation by sterically inhibiting
the binding of activator proteins (20,21). Alternatively, the
methyl binding domain (MBD) proteins, MeCP2, Mbd1
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recruit proteins capable of forming repressive chromatin
structures (22–24). Despite abundant evidence for wide-
spread binding to methylated DNA, the role of the
MBD family in the general repression of methylated
genes has not been supported by knockout studies.
Microarray analyses of tissues from mice with MeCP2
deletions identiﬁed relatively few targets of repression
(25,26). In addition, the exclusively repressive activity of
MeCP2 has been challenged by results showing interaction
with a transcriptional activator (26). Beyond the MBD
proteins, the DNMT and SRA protein families also
have been implicated in recruiting co-repressors to methyl-
ated DNA (27,28), but the general relevance of their
repressive activity remains to be determined (29).
An important aspect of MDR is whether the repressive
activity of methylated CpGs is independent of the sequence
surrounding them. It makes conceptual sense that a repres-
sion system based on DNA methylation would recognize
methylated CpGs independently of their sequence context,
and this possibility is supported by the relatively sequence-
independent recognition of methylated CpGs by the MBD,
SRA and DNMT proteins. Some sequence speciﬁcity,
however, has been demonstrated for MeCP2 in vitro,
whereas Mbd2 showed no speciﬁcity in the same assays
(30). The zinc ﬁnger protein, Kaiso, also shows a limited
form of sequence-speciﬁc recognition of methylated DNA,
as it binds tandem methylated CpGs and ones separated
by up to ﬁve base pairs (31). The RFX proteins, how-
ever, are the best example of transcription factors that
recognize speciﬁc sequences in a methylation-dependent
manner (32). RFX proteins generally bind unmethylated
sequences, but one methylated site appears to regulate the
collagen a2(I) gene (33). Sequence-speciﬁc methylation-
dependent (SSMD) factors may also regulate repression
by and methylation of certain repetitive elements and
imprinting control regions (ICRs) (34,35). In summary,
although much evidence supports sequence-independent
recognition of methylated CpGs, regulation by SSMD pro-
teins remains a real possibility.
As a model for gene regulation by speciﬁc methylated
sequences, we focused on the Igf2/H19 ICR. The methyl-
ated paternal ICR initiates the silencing of H19 from its
position 2kb upstream of the promoter (34). Notably, no
defects in H19 imprinting have been reported in MeCP2
or Mbd2 knockout mice (36). Therefore, we examined
whether key methylated CpGs and their surrounding
sequence are essential for repression by the methylated
ICR. To eliminate eﬀects of both promoter and plasmid
methylation, we used a CpG-free reporter plasmid to
examine how MDR acts over a distance and found that
the methylated ICR exhibits strong repressive activity that
depends on the sequence surrounding key methylated
CpGs. In contrast, control methylated fragments showed
little or moderate repressive activity, despite having CpG
numbers and densities similar to or higher than the ICR.
Our results suggest that some examples of MDR rely on
SSMD repressors for strong MDR activity, whereas gen-
eral CpG methylation may exhibit only weak or moderate
repressive activity.
MATERIALS AND METHODS
Cell cultureand transfections
All cells were cultured at 378Ci n5 %C O 2 in DMEM
supplemented with 10% fetal bovine serum. Plasmids
were methylated with SssI (NEB) overnight and puriﬁed
with silica membrane spin columns (Epoch). Mock methyl-
ations without enzyme were performed in parallel.
Methylation status of plasmids was conﬁrmed by agarose
gel electrophoresis and ethidium bromide staining
after digestion with BstUI, HhaI and HpaII. Only DNA
showing no digestion was used in transfections. Transient
transfections of cells in 6-well plates were performed
according to the manufacturer’s protocol, using 3ml
of Fugene (Roche) or Mirus TransIT-LT1 (Mirus) mixed
with 0.9mg of the reporter plasmids and 0.1mg of pCMV-
Luc. Cells were harvested directly with 1  Reporter Lysis
buﬀer (Promega) after 48h. b-Galactosidase activity was
determined using chlorophenol red b-D-galactopyranoside
(CPRG) as substrate. Luciferase reactions were performed
according to manufacturers protocol (Promega Bright
Glo). Absorbance and luminescence values were measured
on a Tecan ULTRA Evolution instrument. Relative
repression for each methylated and unmethylated plasmid
pair was calculated after normalizing the b-galactosidase
levels to luciferase activity. Student’s t-test was used to
compare results obtained for each methylated and
unmethylated plasmid pair.
Stable transfections were performed with Fugene or
LT1at a 3:1 ratio with 1mg of reporter plasmid in 6cm
dishes. After 2 days, cells were passaged onto 10cm plates
and selected with G418 for 10–14 days. The resulting colo-
nies were passaged onto 6cm plates and harvested
when nearly conﬂuent. Cells were scraped from their
plates, pelleted and lysed with 1  Reporter Lysis buﬀer.
b-Galactosidase activities were normalized to total protein
in the lysates (Biorad) and used to calculate relative
repression of each methylated plamsid compared with
its unmethylated version. For azaC treatment, 10
4 stably
transfected cells were passaged onto 12-well plates,
cultured for 24h, and treated with freshly prepared
5-azacytidine at 10mM for 3 days.
Plasmid constructs
To facilitate cloning, pCpGvitro-neo-lacZ (InvivoGen)
was modiﬁed by adding an EagI site to the 50 end of the
CMV enhancer and replacing the SpeI site with a BamHI
site at the 30 end of the enhancer to create pCpGfree. To
construct pCpGfree2, the CMV enhancer was excised
from pCpGfree and replaced with a linker containing a
BamHI site. After ampliﬁcation from NcoI to BamHI
(base pairs 1140–3589; Genbank accession number
AF049091), the wild-type ICR and the mutant ICRs,
CpG–Shift1 and -Shift2 (described below), were ligated
into pGEM-T Easy and sequenced. EagI–BamHI frag-
ments from these three constructs were inserted into
EagI and BamHI digested pCpGfree, which excises the
CMV enhancer and places the fragments upstream of
the EF-1a promoter. To construct pCpGfree-Lam,
the 2.3kb lambda HindIII fragment (base pairs
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digested with EagI and BamHI were made blunt with
Klenow and ligated together. To construct pCpGfree-
Igf2r, a PvuII fragment from the Igf2r DMR2 (base
pairs 5164–8101; accession number AF151173; a generous
gift of Denise Barlow) was excised from pUC19 with
EcoRI and BamHI, and a three-part ligation was per-
formed to insert the fragment into EcoRI and BamHI
digested pCpGfree. To construct pCpGfree-pBS, a por-
tion of pBluescriptII KS(-) overlapping the bla gene and
the f1 origin (base pairs 1982–2961, 1–153; accession
number X52329) was ampliﬁed with forward and reverse
primers containing EagI and BamHI sites, respectively,
and inserted into EagI and BamHI digested pCpGfree.
To construct pCpGfree-CpG1 and -CpG2, the AatII
and BamHI fragment from pCpGfree-ICR was replaced
with the same fragments from the mutant ICRs (gener-
ously provided by P. Szabo and M. Bartolomei, respec-
tively). The H19 promoter region (base pairs 4785–5527;
accession number AF049091) was ampliﬁed with
upstream and downstream primers containing BamHI
and HindIII sites, respectively, and inserted into BamHI
and HindIII digested pCpGfree2. Multimers of the CTCF
sites and their mutants were inserted into the BamHI site
of pCpGfree2. Oligonucleotides for each CTCF site are as
follow. The lower case letters indicate non-ICR sequence.
CTCF sites—Site 1: gatcGGAGTTGCCGCGTGGTGG
CAGCAAA; Site 2: gatcCAGGGTTGCCGCACGGCG
GCAGTG; Site 3: gatcATGCTACCGCGCGGTGGCA
GCC; Site 4: gatcGATGCCGCGTGGTGGCAGTAC
Mutant CTCF Site 1—MutA: gatcGGAGTTGCaGCGT
GGTGGCAGCAAA; MutB: gatcGGAGTTGCGaGTG
GTGGCAGCAAA; MutC: gatcGGAGTgtaCGCGTGG
TGGCAGCAAA.
The ICR mutants, CpG-Shift1 and CpG-Shift2, were
constructed by a combination of ligating multiple
double-strand oligonucleotides containing the appropriate
mutations and overlapping PCR with primers containing
BbsI sites to create four subfragments of the ICR. After
sequencing the four mutant subfragments in pGEM-T
Easy, they were excised with BbsI to generate complemen-
tary 50 overhangs of unique ICR sequence and ligated
together to generate the complete ICR. ICR-Mut5 was
constructed similarly, with the mutations introduced by
overlapping PCR that generated three fragments with
BbsI ends that when digested and ligated together
formed the complete ICR. After subfragment ligation,
the three mutants were ampliﬁed and inserted into
pGEM-T Easy and pCpGfree as described above. All
PCR-based constructs were sequenced to ensure ﬁdelity.
Further details and primer sequences are available upon
request.
Southern blots
Genomic DNA was isolated from cell pellets remaining
after extraction of stably transfected cells with 1 
Reporter lysis buﬀer. DNA puriﬁcation, restriction digests
and Southern blotting were performed using standard
methods. Hybridization was performed with random
primed probes in Rapid-Hyb according to manufacturer’s
protocol (Amersham).
RESULTS
The Igf2/H19 ICRexhibits sequence-specific MDR
To address the role of CpG number, density and sequence
surrounding the CpGs in MDR, we examined the repres-
sion activity of diﬀerent methylated sequences. Most of
our eﬀort focused on the ICR from the Igf2/H19 locus
because of our interest in genomic imprinting and because
ICR deletions suggest that the methylated paternal region
represses transcription from a distance (34,37). We also
tested fragments from bacteriophage lambda and
pBluescript (pBS), and the diﬀerentially methylated
region 2 (DMR2) located in the second intron of the
imprinted Insulin-like growth factorII receptor (Igf2r)
gene. DMR2 controls the imprinting of Igf2r and includes
a promoter for a non-coding RNA that is silenced by
DNA methylation on the maternal allele (38). The
lambda and pBS fragments were chosen because they
are unlikely to have binding sites for transcription factors
or SSMD proteins, except by chance. In addition, the
2.3kb lambda fragment has almost the same CpG
number and density (CpGs/kb) as the 2.4kb ICR. The
1.1kb pBluescript fragment also has the same number of
CpGs as the ICR, but its CpG density is 2.2-fold higher
(Table 1). The Igf2r DMR2 has 45 more CpGs and a 33%
higher CpG density than the ICR, which could give it a
higher level of MDR activity. The number of tandem and
closely spaced CpGs, which are potential binding sites for
the repressor Kaiso, also diﬀers between the fragments
(Table 1) (31).
To measure MDR activity, we used derivatives of
pCpGvitro-neo-LacZ (pCpGfree), a commercially avail-
able reporter plasmid that is completely devoid of CpGs.
pCpGfree has a 200bp human elongation factor-1a
(EF-1a) promoter fused to a lacZ reporter gene, the
SV40 enhancer/promoter driving a neomycin resistance
gene, and three diﬀerent matrix attachment regions, all
of which were modiﬁed to be free of CpGs. To simplify
inserting test fragments upstream of the promoter, we
constructed two versions of pCpGfree with additional
restriction sites that include one and two CpGs in
Table 1. CpG characteristics of test sequences
Sequence Length CpG
number
CpG
density
a
Closely
spaced
CpGs
b
ICR 2.4 73 30.0 23
CpG-Shift1 2.4 73 30.0 10
CpG-Shift2 2.4 73 30.0 1
pBS 1.1 73 66.4 28
Lambda 2.3 66 28.7 15
Igf2 DMR2 2.9 117 40.3 34
H19 promoter 0.74 28 38.0 7
aNumber of CpGs per 1kb.
bNumber of CpGs separated by 5bp or less.
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after insertion of the test sequences. Using an essentially
CpG-free reporter plasmid allowed us to assess the eﬀects
of insert methylation on transcription without interference
from plasmid-derived CpGs and without concerns about
steric hindrance of promoter factors or the spreading of
DNA methylation.
Modiﬁed pCpGfree constructs with the four test frag-
ments were fully methylated using the bacterial methylase
SssI and transiently transfected into F9 cells, an embry-
onic carcinoma line. Mock methylated versions of each
plasmid were transfected in parallel. Relative to their
unmethylated controls, expression from the methylated
pCpGfree-ICR and -pBS was repressed 14- and 5-fold,
respectively (Figure 1A). In contrast, methylated plasmids
containing the lambda fragment and the Igf2r DMR2
showed less than 2-fold repression. When compared with
the strongly repressive ICR sequence, the other test
sequences with similar or higher CpG numbers and den-
sities showed less inhibition, suggesting that MDR activity
depends more on the methylated sequence than CpG
number or density.
The transient transfections indicated that not all
methylated sequences are capable of substantial transcrip-
tional repression. Transfected plasmids, however, might
not be packaged completely into chromatin, and the
apparent lack of repression by the methylated lambda
fragment and Igf2r DMR2 could reﬂect the absence of
properly assembled chromatin. To address whether
MDR requires normal chromatin, we selected F9 and
NIH3T3 transfectants for stable integration of the repor-
ter plasmids and assayed the eﬀects of DNA methylation
on transcription. In F9 cells, transcriptional repression by
the methylated ICR was dramatic and ranged from  900-
to over 3000-fold in separate transfection experiments
(Figure 1B). Repression by the methylated ICR was
nearly complete, and the reporter reactions had to be incu-
bated over 100-fold longer than the unmethylated controls
to see signiﬁcant enzymatic activity. Although consider-
ably less repressive than the ICR, the methylated pBS
fragment inhibited reporter expression from 30- to
115-fold compared with the unmethylated plasmid. By
contrast, the lambda fragment and the Igf2r DMR2
showed only a modest 1.1–3.1-fold repression when
methylated (Figure 1B).
In stable transfections of 3T3 cells, the methylated ICR
inhibited transcription 70-fold on average, compared
with the 2200-fold seen in F9 cells (Figure 1C).
Similarly, relative repression by the methylated pBS frag-
ment was 17-fold lower than in F9 cells. Both the lambda
and DMR2 fragments again averaged less than 2-fold rel-
ative repression when methylated (Figure 1C). For both
F9 and 3T3 cells, we note that the unmethylated ICR and
pBS plasmids averaged expression that was roughly 3-fold
higher than or equal to the pCpGfree reporter, respec-
tively (Figure 1D). Therefore, most of their decrease in
expression upon methylation was due to inhibition of
the reporter promoter and not to a loss of activation by
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Figure 1. Sequence dependence of methylation-mediated repression. (A) Relative repression of methylated reporter plasmids in transient transfections
of F9 cells. (B) Logarithmic graph of relative repression of methylated reporter plasmids in stable transfections of F9 cells. (C) Same as in B, except
NIH3T3 cells were stably transfected. (D) Expression of unmethylated reporter plasmids normalized to unmethylated pCpGfree in stable transfec-
tions of F9 (empty) and 3T3 cells (gray). (A–D) Mean values and standard deviations for each graph were derived from three independent
experiments and depict the ratio of expression from the unmethylated and methylated version of each plasmid. All means have P-values <0.05
when compared with unmethylated plasmids, except where indicated by asterisk. Methylated sequences are indicated next to the graphs. Sequences:
ICR, Igf2/H19 imprinting control region; Lam, 2.3kb lambda HindIII fragment; pBS, fragment of pBluescript; Igf2r, DMR2 from the Igf2r gene;
pCpGfree, empty reporter plasmid.
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DMR2 fragments also exhibited no or only approximately
2-fold induction, respectively, indicating that much of
DMR2’s repression may reﬂect the loss of activation
(Figure 1D). To address whether demethylation could
explain their diﬀerent repression activity, methylation sen-
sitive Southern blot analysis was performed on genomic
DNA isolated from the stably transfected polyclones. For
each methylated sequence and in both cell lines, little or no
demethylation was detected (data not shown). Taken
together, the dramatically diﬀerent repressive activity of
the four sequences in the context of normal chromatin
suggests that the strength of MDR at a distance varies
with sequence context of the methylated CpGs and not
simply with their number or density.
CpGs associated withCTCF sites arenecessary for
sequence-specific MDR
The apparent sequence speciﬁcity of the MDR could be
explained by repressor proteins that bind in a sequence-
speciﬁc and methylation-dependent manner to the ICR
and pBS inserts. To determine whether the strong repres-
sion by the ICR is sequence-dependent, we constructed
CpG-Shift1 and CpG-Shift2, two mutant ICRs with
altered CpG patterns but the same number of CpGs. In
each mutant ICR, the positions of CpGs were shifted
slightly by mutating either the C or G of a CG dinucleo-
tide and creating a replacement by altering the base next
to a nearby C or G. More speciﬁcally, the 73 CpGs in the
ICR were divided into 13 CpGs associated with the four
binding sites for the insulator protein CTCF and the 60
CpGs outside these sites. In CpG-Shift1, the positions of
58 CpGs outside the CTCF sites were changed, whereas
CpGs associated the CTCF sites were left unaltered
(Figure 2 and Supplementary Figure S1). We speciﬁcally
separated nearly all CpGs by at least six nucleotides to
prevent the binding of Kaiso, which can bind sequences
with up to ﬁve nucleotides between two methylated CpGs
(31). In CpG-Shift2, the 60 CpGs are in the same position
as in CpG-Shift1, and 10 of the 13 CTCF site CpGs also
were rearranged and separated by more than ﬁve bases. It
is likely that the CpG rearrangement in CpG-Shift2
destroyed the four CTCF sites, but we mutated each site
further to ensure equal elimination (Figure 2) (39). The
purpose of the CpG-Shift mutants was to retain the
same CpG number and as much of the ICR sequence
and local CpG density as possible, while altering potential
sites for proteins that bind the ICR in a methylation- and
sequence-dependent manner. Thus, these mutants provide
comparison sequences that are more than 93% identical
to the wild type ICR, but with most or nearly all of the
CpGs in diﬀerent contexts. This is in contrast to simply
mutating CpGs, which would make it more diﬃcult to
distinguish the eﬀects of reducing CpG number from
mutating speciﬁc binding sites.
After stable transfection into F9 cells, the methylated
CpG-Shift1 plasmid showed dramatically lower reporter
expression than its unmethylated version (Figure 3A).
In separate experiments, relative repression by the methyl-
ated CpG-Shift1 was similar to the wild type ICR and
ranged from about 500- to over 1000-fold. Although
their ranges of relative repression activity overlapped,
the absolute expression from the methylated CpG-Shift1
plasmid was generally higher than that of the methylated
ICR plasmid (data not shown). Taken together, these
results suggest that altering the CpGs outside of the
CTCF sites had only a minimal eﬀect on the ICR’s repres-
sive potential. In sharp contrast, reporter expression in
F9 cells stably transfected with the methylated CpG-
Shift2 plasmid was no more than 3-fold lower than the
expression in cells carrying the unmethylated plasmid
(Figure 3A), indicating that altering the CpGs associated
with the CTCF sites destroyed the ICR’s strong repressive
potential. Curiously, expression from the unmethylated
CpG-Shift2 plasmid in F9 cells averaged about 20-fold
lower than that seen with the unmethylated CpG-Shift1
and ICR plasmids (Figure 3C). However, even with its
reduced expression potential, activity from the methylated
CpG-Shift2 plasmid was on average 25-fold higher than
the methylated CpG-Shift1 plasmid. In 3T3 cells, the rel-
ative repression activity of methylated CpG-Shift1 and
-Shift2 paralleled that seen in F9 cells, but CpG-Shift1’s
level of repression was much greater in F9 (Figure 3A
and B). Also, expression from the unmethylated CpG-
Shift2 plasmid in 3T3 cells was comparable to that
of the unmethylated ICR and CpG-Shift1 plasmids
(Figure 3C). Importantly, expression from the unmethyl-
ated CpG-Shift1 plasmid in both cell lines was comparable
to that of the ICR and averaged only 2.6-fold more than
the empty reporter plasmid (Figure 3C). Thus, the
1000-fold repression by methylated CpG-Shift1 indicates
Figure 2. CTCF sites in the ICR mutants. Wild-type sequence sur-
rounding the four CTCF sites in the Igf2/H19 ICR is shown in
black, except for CpGs, which are green. In the mutant ICRs, altered
bases are shown in blue, except for new CpGs, which are red. Further
description of the ICR mutants is in the text and Supplementary
Figure S1. The core of each CTCF site is underlined.
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ing. As with the other test fragments, little or no demethy-
lation was detected by methylation sensitive Southern blot
analysis of DNA from the stable transfectants (data not
shown). The diﬀerence in MDR between CpG-Shift1 and
CpG-Shift2 suggests that the sequences surrounding the
CpGs associated with the CTCF sites are essential for the
strong repression activity of the methylated ICR.
From the dramatic diﬀerence in MDR activity between
the wild type and CpG-Shift2 ICRs, it was clear that
repression activity centered on the CpGs associated with
the CTCF sites. However, the somewhat higher expression
from the methylated CpG-Shift1 plasmid suggested that
rearranging the ICR’s CpGs removed some inhibitory
activity recruited by methylation outside of the CTCF
sites. To determine if these 60 CpGs have repression activ-
ity when methylated and to conﬁrm the importance of the
CTCF site CpGs, we examined the MDR activity of two
ICRs containing diﬀerent mutations within the four CTCF
binding sites. In ICR-CG1, a total of 10 CpGs and 37
bases within the CTCF sites were mutated, which elimi-
nates CTCF binding (40) (Figure 2). In ICR-CG2, nine
CpGs and 14 additional bases within the CTCF sites were
mutated, but CTCF binding is retained (41) (Figure 2).
After methylation and stable transfection into 3T3 cells,
the methylated ICR-CG1 and  CG2 plasmids
showed no more than 5-fold lower activity than the
unmethylated controls (Figure 3B). Southern analysis con-
ﬁrmed that both mutants maintained their methylation
(data not shown). Together with the CpG-Shift1 and
-Shift2 results, the substantial loss of MDR activity exhib-
ited by ICR-CG1 and -CG2 further implicates the
CTCF site CpGs in the methylated ICR’s repressive
activity.
One concern not addressed by the CpG-Shift and CG
mutants is that the MDR activity of a sequence could
depend on particular arrangements or patterns of CpG
clusters that may form optimal sites for the binding of
multiple methylation-dependent, but sequence non-
speciﬁc repressors. As all four mutant ICRs have dis-
rupted both CpG patterns and sequence context, we
constructed ICR-Mut5 in which only bases surrounding
the CTCF site CpGs were altered, but the CpG patterns
are intact (Figure 2). Despite these minimal changes,
methylated ICR-Mut5 demonstrated low levels of MDR
that were similar to ICR-CG1 and -CG2 (Figure 3B).
Thus, not only are the CTCF site CpGs necessary for the
methylated ICR’s repression activity, but their surround-
ing sequences are necessary as well. These results indicate
that together they form part of the recognition site for
SSMD repressors. We note, however, that the moderate
amount of MDR activity exhibited by ICR-Mut5 and the
CG mutants indicates that the CpGs away from the
CTCF sites contribute to the full inhibitory activity of
the methylated ICR.
As a control, we conﬁrmed that the strong MDR activ-
ity of the methylated ICR and CpG-Shift1 fragments was
due to DNA methylation by measuring induction of the
reporter plasmid after treating cells with the DNA methyl-
transferase inhibitor 5-azacytidine (azaC). In polyclones
of F9 cells carrying the methylated ICR or CpG-Shift1
plasmids, 3 days of culture with azaC induced b-gal
expression 30- and 300-fold, respectively (Figure 4).
Only 2.5-fold induction by azaC was seen in cells trans-
fected with the methylated CpG-Shift2 plasmid (Figure 4).
Activation of the methylated ICR and CpG-Shift1 plas-
mids by azaC treatment indicated that at least some of
their repression is attributable to DNA methylation. The
modest induction of the methylated CpG-Shift2 plasmid
by azaC further suggested that methylation has a compar-
atively small eﬀect on its expression level.
CTCF site CpGs andsurrounding bases aresufficient for
sequence-specific MDR
After establishing their necessity, we determined if the
CTCF site CpGs are suﬃcient for MDR from a distance.
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Figure 3. Sequence-speciﬁc repression by CpGs associated with CTCF sites in the ICR. (A) Logarithmic graph of the relative repression of
methylated plasmids in stable transfections of F9 cells. (B) Graph of the relative repression of methylated plasmids in stable transfections of
NIH3T3 cells. (C) Expression of unmethylated reporter plasmids relative to unmethylated pCpGfree in stable transfections of F9 (empty) and
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798 Nucleic Acids Research, 2009, Vol. 37,No. 3We inserted ﬁve copies of portions of the four CTCF sites
into pCpGfree, and stably transfected the methylated and
unmethylated plasmids into 3T3 cells. The methylation of
sequences from CTCF Site 1, 2 and 4 lead to strong
repression of the reporter, while methylated Site 3
showed little repressive activity (Figure 5A). To address
sequence speciﬁcity of the repression, multimers of three
mutant versions of CTCF Site 1 were tested for MDR
activity. Mut1A and B have point mutations in one of
Site 1’s tandem CpGs. In Mut1C, three bases adjacent
to the tandem CpGs were altered. In stably transfected
3T3 cells, methylated multimers of the three mutants
had essentially no repressive activity (Figure 5B). These
results indicate that three of the four elements are suﬃ-
cient for strong MDR of transcription and that both the
methylated CpGs and their surrounding sequence are
required for repression.
Repressive activity ofthe methylated ICR is
cell-type specific
To address whether the level of MDR exerted by the dif-
ferent sequences showed any cell-type speciﬁcity, we stably
transfected Hela and Cos7 cells with methylated and
unmethylated reporter plasmids and determined their rel-
ative expression levels. In Hela cells, the methylated ICR,
CpG-Shift1 and CpG-Shift2 showed moderate repression,
but unlike in F9 and 3T3 cells, each fragment repressed
within the same 2–4-fold range (Figure 6A). Results from
Cos7 cells were even more surprising as reporter
expression from the methylated and unmethylated wild-
type and mutant ICR plasmids were essentially identical.
Similarly, the methylated lambda and pBS fragments
showed no repression in Cos7 cells (Figure 6B).
Southern analysis demonstrated that the methylated plas-
mids retained their modiﬁcation in both cell types, indicat-
ing that loss of methylation did not explain their
expression (data not shown). These results demonstrate
that the strength of repression mediated by upstream
DNA methylation is cell-type speciﬁc, in addition to
sequence-dependent.
H19promoter is notsilenced byDNA methylation
The ICR’s sequence-speciﬁc MDR activity exerts its
eﬀects over the 200bp EF-1a promoter, but several
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All means have P-values<0.05 when compared with untreated parallel
cultures. Abbreviations are in Figure 1.
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results suggest that only speciﬁc methylated squences
have strong MDR activity, sequence non-speciﬁc MDR
could be highly repressive locally, but have little ability
to act over even short distances. To test whether the
strength of MDR is more independent of sequence when
acting locally, we replaced the CpG-less EF-1a promoter
in pCpGfree with a fragment of the H19 promoter that
has 28 CpGs. Methylation of the paternal H19 promoter
appears to be essential for its transcriptional repression
in vivo, making it a useful test of local repression by
methylation (8). After stable transfection of F9 cells, the
methylated H19 promoter plasmid showed roughly 3-fold
lower b-gal expression than the unmethylated control
(Figure 7). Similar results were seen in 3T3 cells
(Figure 7). While this repression represents a roughly
70% reduction in activity, these results show that DNA
methylation is not suﬃcient for silencing of the H19 pro-
moter and could indicate that the strength of local MDR
also depends on the sequence being methylated.
DISCUSSION
DNA methylation has been proposed to inhibit transcrip-
tion by sterically blocking the binding of activator pro-
teins and by creating sites for proteins that bind
methylated CpGs and recruit transcriptional co-repressors
(20–24). Recognition of methylated CpGs is generally
thought to show little inﬂuence from the sequence sur-
rounding them and to occur in almost all cell types. In
support of these ideas, proteins implicated in MDR, such
as the MBD, SRA and DNMT families, show limited
sequence speciﬁcity, and many are broadly expressed
(28,36). On the other hand, the extent that these proteins
mediate MDR activity in vivo remains controversial for
the MBDs and undetermined for the others (26,29). In
contrast to predictions of sequence and cell-type indepen-
dence, we found that the strength of MDR from a distance
varied over a 1000-fold between diﬀerent methylated
sequences and between cell lines. These results are consis-
tent with the possibility that sequence-speciﬁc MDR may
be common amongst genes normally silenced by DNA
methylation and that repression levels may vary between
both normal and transformed cell types.
Advantages of aCpG-free reporter plasmid
In many studies of MDR, the observed eﬀects of DNA
methylation on transcription are likely to be inﬂuenced by
methylation not only of the test sequence but also of the
standard CpG-rich reporter constructs used in most
experiments. By employing a reporter that is essentially
devoid of CpGs and by placing test sequences upstream
of a CpG-less promoter, we avoided any eﬀects of plas-
mid-derived methylation as well as any steric hindrance of
promoter factors. Similar experiments have been per-
formed with standard plasmids by methylating only spe-
ciﬁc subsets of the plasmid (19,42). In our system,
however, the CpG-free plasmid also cannot acquire
methylation. Finally, most of our assays involved stable
transfections to ensure that repression was measured in
the context of complete chromatin, while site of integra-
tion eﬀects were minimized by assaying polyclones. These
advantages allow a more independent assessment of a
methylated sequence’s repression potential in normal
chromatin. One limitation of the system is that the repres-
sive activity of DNA methylation must overcome any acti-
vator proteins binding to the EF-1a promoter. A weaker
or partially silenced promoter could detect lower levels of
MDR activity.
Sequence-specific repression by the methylated
Igf2/H19 ICR
To address the mechanism of MDR from a distance, we
focused on the ICR of the Igf2/H19 locus, as the methyl-
ated paternal ICR is required to silence H19 expression
from its position 2kb upstream of the promoter (34).
Initially, we assumed that the ICR’s MDR activity
reﬂected the number or density of methylated CpGs.
Compared with the ICR, however, the control lambda
and Igf2r DMR2 fragments showed about 1000-fold
lower levels of MDR activity in F9 cells, despite having
CpG numbers and densities similar to or higher than the
ICR. Although these results strongly support a sequence-
speciﬁc component to the ICR’s MDR activity, compar-
ing completely diﬀerent sequences introduces several
caveats to interpreting their relative levels of MDR. One
concern is the binding of the repressor Kaiso to
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Figure 7. Methylation-mediated repression of the H19 promoter.
Graphs of the relative repression of methylated H19 promoter plasmid
in stable transfections of F9 and 3T3 cells. The reporter promoter in
pGpGfree2 was replaced with the H19 promoter. Mean values and
standard deviations are from three independent experiments. Both
means have P-values<0.05 when compared with unmethylated control
plasmids.
800 Nucleic Acids Research, 2009, Vol. 37,No. 3methylated tandem or closely spaced CpGs (31), but our
results showed no correlation between potential Kaiso
sites and MDR. We also found no consistent correlation
between MDR activity and the average CpG distance
from the TATA box or the number of CpGs within
200bp of the promoter. The pBluescript fragment, how-
ever, scores highest in these two measures of ‘CpG prox-
imity’, which could explain its greater MDR activity than
the other controls. Finally, the low MDR of the three
control fragments could reﬂect the binding of methyla-
tion-insensitive activators that drove demethylation of
the test sequences or activated transcription. Although
we cannot exclude localized loss of methylation,
Southern analysis of the integrated methylated plasmids
did not show signiﬁcant demethylation. In addition, all of
the unmethylated fragments we examined showed no more
than 2–3-fold induction of the reporter, suggesting that
they do not bind strong activators.
To reduce the caveats of comparing unrelated
sequences, we generated the CpG-Shift1 and CpG-Shift2
mutants. By altering only the CpG arrangement, the two
mutants retain >93% identity with the ICR, have the
same number of total and proximal CpGs, and have
nearly the same average CpG distance from the promoter
as the wild type ICR. Although we separated CpGs by at
least ﬁve bases, similar local density and spacing of CpGs
was maintained, as both parameters were thought to inﬂu-
ence the repressive activity of the ICR. Thus, the
 600-fold diﬀerence in the relative repression between
methylated CpG-Shift1 and -Shift2 in F9 cells focused
attention on the CpGs associated with the CTCF sites,
with fewer of the variables associated with unrelated con-
trol sequences. Furthermore, the reduced MDR activity of
the ICR-CG1 and ICR-CG2 mutants corroborated
these results. We note, however, that the unmethylated
CpG-Shift2 plasmid showed reduced expression in F9,
but not 3T3 cells. Mutation of the CTCF sites in CpG-
Shift2 may have reduced its expression, but this seems
unlikely as the wild-type ICR activated the reporter only
3-fold. Alternatively, we may have created sites for repres-
sors expressed in F9 cells. In either case, its reduced
expression does not alter our conclusion that SSMD
repressors bind to the CTCF site CpGs.
We also considered that speciﬁc arrangements of
methylated CpGs may be optimal for binding of repres-
sors, and if so, then CpG pattern will dictate repression
activity. In the ICR-Mut5, the CpG arrangement of the
entire ICR is intact, but the bases surrounding the CTCF
site CpGs are altered. This mutant showed greatly reduced
MDR activity, indicating that CpG pattern is not critical
for repression by the methylated ICR and that bases sur-
rounding the methylated CTCF site CpGs are essential for
the binding of SSMD repressors. The sequence-dependent
repression by multimers of  25bp sequences derived from
the ICR’s CTCF sites conﬁrmed these results. Moreover,
the methylated multimers have no more than 16 CpGs,
suggesting that the additional 57 CpGs in the ICR are
not critical for its MDR activity.
The ICR’s strong MDR activity is likely due to the
binding of SSMD repressors with recognition elements
that include unmodiﬁed bases and methylated CpGs.
The RFX proteins are the best examples of transcription
factors that can bind speciﬁc sequences containing methyl-
ated CpGs (32), although the overall relevance of this
activity for RFX function or for methylation-dependent
gene regulation is unknown. Similarly, Kaiso and MeCP2
exhibit intermediate sequence speciﬁcity, but its relevance
to genome-wide MDR and H19 repression remains to be
determined (30,31). We found that all three proteins bind
at least some of the methylated CTCF site elements
in vitro, but they also bind mutant elements that have no
repressive activity, suggesting they are not involved in the
repression or are not suﬃcient (data not shown).
Identifying the proteins responsible for the ICR’s MDR
activity will allow us to assess their role in gene repression
by DNA methylation.
Repression by the methylated Igf2/H19 ICR invivo
The strong repression mediated by the three methylated
CTCF sites in cultured cells raises the question of whether
they also function in the mouse. However, knockin mice
with the CTCF site mutant ICRs, ICR-CG1 and -2,
show no defects in H19 promoter repression or in paternal
ICR methylation (40,43). Although these results indicate
that the CTCF site CpGs are not necessary for repression
of H19 in normal cells, they do not rule out redundancy
with other CpGs in the ICR. Consistent with this possibi-
lity, both methylated ICR-CG mutants retain some
repressive activity in 3T3 cells, which may reﬂect binding
of SSMD repressors to CpGs outside of the CTCF sites.
Similarly, the CTCF site CpGs are not altered in CpG-
Shift1, but it has weaker MDR activity than the wild type
ICR. Using BLAST analysis, we identiﬁed three CpG-
containing sequences with similarity to the minimal
repressive sequence associated with CTCF Site 1 (data
not shown). The three sequences are mutated in CpG-
Shift1 and could explain its reduced MDR activity.
Conversely, they are not altered in ICR-CG1 and -2,
and may provide suﬃcient activity to repress paternal
H19 in mice with these mutant ICRs (40,43). Notably,
except for knockdown of Mbd3 (which does not bind
methylated DNA), deletion of individual MBD genes
does not cause loss of H19 repression (30,44).
Repression of themethylated H19promoter
The low levels of MDR exhibited by some of the control
fragments and mutant ICRs could indicate that DNA
methylation generally is not suﬃcient to nucleate the
spreading of transcriptional silencing, but does not
exclude that methylation may have strong repressive activ-
ity when acting locally. To address this issue, we measured
how methylation of the H19 promoter aﬀected its tran-
scriptional activity and found a moderate 2–4-fold repres-
sion by complete methylation of the promoter. We have
not distinguished whether the CpG methylation has any
direct eﬀect on activator binding, but the absence of
strong silencing suggests that DNA methylation generally
is only moderately inhibitory. Although more promoters
will have to be examined in detail, we speculate that many
promoters subject to strong MDR are inhibited by the
activity of SSMD repressors. In any case, the CpG-free
Nucleic AcidsResearch, 2009, Vol.37,No. 3 801reporter system provides an excellent system to identify
SSMD repressor-mediated eﬀects. For example, promot-
ers that are repressed by DNA methylation and also exhi-
bit strong MDR from at distance are likely to be targets
for SSMD repressors.
Cell-type-dependent repression by theIgf2/H19 ICR
Given the widespread repression of paternal H19 in vivo,
we expected the ICR’s potent MDR activity to occur in all
cell types. However, repression activity of the methylated
ICR was greatly reduced or absent in Hela and Cos7 cells
and was equal to that of the control sequences. Thus, cell-
type-speciﬁc factors appear to be mediating the methyl-
ated ICR’s repressive activity, which is consistent with the
tissue-speciﬁc loss of paternal H19 repression in mice with
a partial ICR deletion (37). One explanation that we
cannot completely exclude is the presence of cell-type-
speciﬁc promoter binding factors that eﬀectively block
the repression by the methylated sequences in Cos7 or
Hela cells. We suspect, however, that if the methylated
ICR has strong repressive activity in these cells, then it
would show measurable repression relative to the control
fragments, regardless of bound activator or insulator
proteins.
CONCLUSION
Our results suggest that to understand the how methylated
sequences mediate repression, each one may have to be
considered individually. Our limited sample indicates
that the sequence context of methylated CpGs is a key
determinant of MDR strength, while CpG number and
density are comparatively poor predictors. Sequence-spe-
ciﬁc binding of repressors to methylated sequences might
explain results showing repression mediated by a single
methylated CpG (45,46) or how low-level methylation
by site-speciﬁc methylases can be repressive (47).
Similarly, sequence-speciﬁc MDR could explain how a
patch of DNA methylation inhibits an unmethylated pro-
moter or blocks elongation (19,48). Sequence speciﬁcity is
also consistent with the proposal that some promoters
have ‘catalyst’ CpGs that, upon methylation, nucleate fur-
ther promoter methylation (49). Finally, all methylated
sequences exhibited at least 1.3–4-fold repression in most
cell lines, which may reﬂect limited sequence-independent
repression initiated by DNA methylation. Thus, cells may
have two types of methylation-mediated repression, one
strong and sequence-speciﬁc and one weaker and sequence
non-speciﬁc.
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